Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Feb. 16, 1998

Targretin demonstrates high preclinical efficacy in breast tumors

Feb. 16, 1998

Vical and Centocor sign agreement for "naked" DNA technology

Feb. 16, 1998

Variagenics granted U.S. patent covering Variagenic Targeting

Feb. 16, 1998

Cyclooxygenase type 2, a potential therapeutic target in colon carcinogenesis

Feb. 16, 1998

Weizmann Institute presents new materials for PDT of cancer

Feb. 13, 1998

Nonpeptide GnRH antagonists prepared at Merck & Co.

Feb. 13, 1998

Phase III milestone reached for Ethyol in new indication

Feb. 13, 1998

Antitumor arabinofuranosylcytosines from Yamasa

Feb. 13, 1998

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Feb. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...